BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36702676)

  • 1. Increased incidence of positive peritoneal lavage cytology early after fine needle aspiration in patients with pancreatic ducal adenocarcinoma.
    Sakamoto T; Onda S; Shirai Y; Tsunematsu M; Okui N; Gocho T; Ikegami T
    Pancreatology; 2023 Mar; 23(2):201-203. PubMed ID: 36702676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic influence of endoscopic ultrasound-guided fine needle aspiration in IPMN-derived invasive adenocarcinoma.
    Suzuki R; Irie H; Takagi T; Sugimoto M; Konno N; Sato Y; Watanabe K; Nakamura J; Marubashi S; Hikichi T; Ohira H
    BMC Cancer; 2018 Oct; 18(1):974. PubMed ID: 30314433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].
    Wu L; Guo W; Li Y; Cheng T; Yao Y; Zhang Y; Liu B; Zhong M; Li S; Deng X; Zhu W
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1171-1178. PubMed ID: 30377133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Hoshi N; Hoshi S; Hirabayashi K; Ogata Y
    Pancreatology; 2017; 17(1):109-114. PubMed ID: 27840175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer.
    Tanemura M; Furukawa K; Mikamori M; Asaoka T; Yasuoka H; Marukawa D; Urata Y; Yamada D; Kobayashi S; Eguchi H
    Sci Rep; 2024 May; 14(1):10199. PubMed ID: 38702437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Resectability Status.
    Sakoda T; Uemura K; Kondo N; Sumiyoshi T; Okada K; Seo S; Otsuka H; Murakami Y; Takahashi S
    J Gastrointest Surg; 2021 Nov; 25(11):2871-2880. PubMed ID: 33768425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative risk factors for positivity of peritoneal lavage cytology in patients with pancreatic ductal adenocarcinoma in the era of neoadjuvant therapy.
    Otsuka H; Uemura K; Kondo N; Sumiyoshi T; Okada K; Seo S; Murakami Y; Takahashi S
    Pancreatology; 2022 Jun; 22(5):583-589. PubMed ID: 35466060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal indication of endoscopic retrograde pancreatography-based cytology in the preoperative pathological diagnosis of pancreatic ductal adenocarcinoma.
    Kawamura R; Ishii Y; Serikawa M; Tsuboi T; Tsushima K; Nakamura S; Hirano T; Ikemoto J; Kiyoshita Y; Saeki S; Tamura Y; Miyamoto S; Nakamura K; Furukawa M; Ishida K; Arihiro K; Uemura K; Aikata H
    Pancreatology; 2022 Apr; 22(3):414-420. PubMed ID: 35219581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic efficacy of liquid-based cytology for solid pancreatic lesion samples obtained with endoscopic ultrasound-guided fine-needle aspiration: Propensity score-matched analysis.
    Hashimoto S; Taguchi H; Higashi M; Hatanaka K; Fujita T; Iwaya H; Nakazawa J; Arima S; Iwashita Y; Sasaki F; Nasu Y; Kanmura S; Ido A
    Dig Endosc; 2017 Jul; 29(5):608-616. PubMed ID: 28160342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of calcifications on diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration for pancreatic ductal adenocarcinoma.
    Koshy AK; Harshavardhan RB; Siyad I; Venu RP
    Indian J Gastroenterol; 2019 Apr; 38(2):128-133. PubMed ID: 30903611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ERCP in the era of EUS-FNA for preoperative cytological confirmation of resectable pancreatic ductal adenocarcinoma.
    Ohtsuka T; Tamura K; Ideno N; Aso T; Nagayoshi Y; Kono H; Ueda J; Takahata S; Aso A; Igarashi H; Ito T; Ushijima Y; Ookubo F; Oda Y; Mizumoto K; Tanaka M
    Surg Today; 2014 Oct; 44(10):1887-92. PubMed ID: 24496980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma.
    Suenaga M; Fujii T; Yamada S; Hayashi M; Shinjo K; Takami H; Niwa Y; Sonohara F; Shimizu D; Kanda M; Kobayashi D; Tanaka C; Nakayama G; Koike M; Fujiwara M; Kondo Y; Kodera Y
    Ann Surg Oncol; 2021 Apr; 28(4):2277-2286. PubMed ID: 32875467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles from pancreatic ductal adenocarcinoma endoscopic ultrasound-fine needle aspiration samples contain a protein barcode.
    Inoue H; Eguchi A; Kobayashi Y; Usugi E; Yamada R; Tsuboi J; Akuta T; Horiki N; Iwasa M; Takei Y
    J Hepatobiliary Pancreat Sci; 2022 Mar; 29(3):394-403. PubMed ID: 34555251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of fine-needle aspiration in patients with resectable pancreatic cancer.
    Johnson DE; Pendurthi TK; Balshem AM; Ross E; Litwin S; Eisenberg BL; Hoffman JP
    Am Surg; 1997 Aug; 63(8):675-9; discussion 679-80. PubMed ID: 9247432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of soluble biomarkers of pancreatic cancer in endoscopic ultrasound-guided fine-needle aspiration samples.
    Souche R; Tosato G; Rivière B; Valats JC; Debourdeau A; Flori N; Pourquier D; Fabre JM; Assenat E; Colinge J; Turtoi A
    Endoscopy; 2022 May; 54(5):503-508. PubMed ID: 34448184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Malignancies in Patients with Inconclusive or Negative Results of Endoscopic Ultrasound-guided Fine-needle Aspiration for Solid Pancreatic Masses.
    Jeong H; Park CS; Kim KB; Han JH; Yoon SM; Chae HB; Youn SJ; Park SM
    Korean J Gastroenterol; 2018 Mar; 71(3):153-161. PubMed ID: 29566476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD10 is useful to identify gastrointestinal contamination in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) cytology from pancreatic ductal adenocarcinoma.
    Vigliar E; Troncone G; Bracale U; Iaccarino A; Napolitano V; Bellevicine C
    Cytopathology; 2015 Apr; 26(2):83-7. PubMed ID: 24754336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Maspin, CK17 and Ki-67 Immunophenotyping in Diagnosing of Pancreatic Ductal Adenocarcinoma in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology.
    Mamdouh MM; Okasha H; Shaaban HAM; Hafez NH; El-Gemeie EH
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3299-3307. PubMed ID: 34711007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors of Endoscopic Ultrasound-Guided Tissue Acquisition for Successful Next-Generation Sequencing in Pancreatic Ductal Adenocarcinoma.
    Park JK; Lee JH; Noh DH; Park JK; Lee KT; Lee JK; Lee KH; Jang KT; Cho J
    Gut Liver; 2020 May; 14(3):387-394. PubMed ID: 31581388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of staging laparoscopy for resectable pancreatic cancer on imaging and the therapeutic effect of systemic chemotherapy for positive peritoneal cytology.
    Fukasawa M; Watanabe T; Tanaka H; Itoh A; Kimura N; Shibuya K; Yoshioka I; Murotani K; Hirabayashi K; Fujii T
    J Hepatobiliary Pancreat Sci; 2023 Nov; 30(11):1261-1272. PubMed ID: 37750024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.